Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?
Double Negative (DN) B cells constitute a B cell population that lacks expression of immunoglobulin D and CD27 memory marker. These cells expand in elderly healthy individuals, but also accumulate prematurely in autoimmune and infectious diseases. COVID-19 is a pandemic infectious disease caused by...
Guardado en:
Autores principales: | Athanasios Sachinidis, Alexandros Garyfallos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PCO Convin S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a8e22766f24afbaaa115f272990e23 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Should we be Afraid of Immune Check Point Inhibitors in Cancer Patients with Pre-Existing Rheumatic Diseases? Immunotherapy in Pre-Existing Rheumatic Diseases
por: Kalliopi Klavdianou, et al.
Publicado: (2021) -
Clinical, Echocardiographic Characteristics and Management Practices in Patients with Rheumatic Valvular Heart Disease
por: Mulugeta T, et al.
Publicado: (2020) -
Clinical Impact of the ABO Blood Type in Patients with Rheumatic Diseases: Is there a Link to the ABO and Rhesus?
por: Gehan I. Salem, et al.
Publicado: (2021) -
Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009) -
COVID-19 and Autoimmune/Autoinflammatory Rheumatic Disease Patients: Lessons Learned and Questions Anticipating Answers
por: Athanasios-Dimitrios Bakasis, et al.
Publicado: (2021)